Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-12 Purchase | 2025-09-16 6:09 pm | LB PHARMACEUTICALS INC | LBRX | Deep Track Biotechnology Master Fund Ltd. Deep Track Capital LP KROIN DAVID 10% Owner | 2,666,666 | $15 | $39,999,990 | 3,352,804 (Indirect Direct) | View |
| 2025-09-12 Purchase | 2025-09-16 4:15 pm | LB PHARMACEUTICALS INC | LBRX | Pontifax Management 4 G.P. (2015) Ltd. 10% Owner | 1,000,000 | $15 | $15,000,000 | 1,411,681 (Indirect) | View |
| 2025-09-12 Purchase | 2025-09-16 4:15 pm | LB PHARMACEUTICALS INC | LBRX | Nussbaum Ran Director | 1,000,000 | $15 | $15,000,000 | 1,411,681 (Indirect) | View |
| 2025-09-12 Purchase | 2025-09-16 3:46 pm | LB PHARMACEUTICALS INC | LBRX | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. Belldegrun Arie Vida Ventures Management Co. LLC 10% Owner | 333,333 | $15 | $4,999,995 | 3,463 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-12 Conversion | 2025-09-16 6:09 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Deep Track Biotechnology Master Fund Ltd. Deep Track Capital LP KROIN DAVID 10% Owner | 17,352,805 | $0 | 3,352,804 (Direct) | View |
Ownership | 2025-09-16 6:07 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Deep Track Special Opportunities Fund LP 10% Owner | 0 | $0 | 666,666 (Direct) | View |
| 2025-09-12 Conversion | 2025-09-16 4:15 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Pontifax Management 4 G.P. (2015) Ltd. 10% Owner | 10,411,681 | $0 | 1,411,681 (Indirect) | View |
| 2025-09-12 Conversion | 2025-09-16 4:15 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Nussbaum Ran Director | 10,411,681 | $0 | 1,411,681 (Indirect) | View |
| 2025-09-12 Conversion | 2025-09-16 3:46 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. Belldegrun Arie Vida Ventures Management Co. LLC 10% Owner | 13,882,243 | $0 | 3,463 (Indirect) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2035-09-09 | LB PHARMACEUTICALS INC | LBRX | Hemrajani Rekha Director | 22,449 | $0 | 22,449 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2035-09-09 | LB PHARMACEUTICALS INC | LBRX | Luse Rebecca Director | 22,449 | $0 | 22,449 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2035-09-09 | LB PHARMACEUTICALS INC | LBRX | Kane William P Jr Director | 22,449 | $0 | 22,449 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2028-06-26 | LB PHARMACEUTICALS INC | LBRX | RUFFOLO ROBERT R Director | 35,715 | $0 | 35,715 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2028-11-13 | LB PHARMACEUTICALS INC | LBRX | PRENSKY ZACHARY Director | 100,260 | $0 | 100,260 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2035-09-09 | LB PHARMACEUTICALS INC | LBRX | Nussbaum Ran Director | 22,449 | $0 | 22,449 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2034-03-03 | LB PHARMACEUTICALS INC | LBRX | Garland J. Scott Director | 43,963 | $0 | 43,963 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2035-02-10 | LB PHARMACEUTICALS INC | LBRX | Silva Richard Anthony SVP, Technical Operations | 89,863 | $0 | 89,863 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2033-08-24 | LB PHARMACEUTICALS INC | LBRX | Eramo Anna Chief Medical Officer | 188,980 | $0 | 188,980 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2035-02-10 | LB PHARMACEUTICALS INC | LBRX | Soffer Gad Chief Business Officer | 256,753 | $0 | 256,753 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 6:25 pm | N/A 2034-11-17 | LB PHARMACEUTICALS INC | LBRX | Turner Heather D Chief Executive Officer | 1,155,391 | $0 | 1,155,391 (Direct) | View |
Ownership | 2025-09-11 6:38 pm | N/A 2035-02-10 | LB PHARMACEUTICALS INC | LBRX | Silva Richard Anthony SVP, Technical Operations | 0 | $0 | 8,964 (Direct) | View |
Ownership | 2025-09-11 11:05 am | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Pontifax Management 4 G.P. (2015) Ltd. 10% Owner | 0 | $0 | 411,681 (Indirect) | View |
Ownership | 2025-09-11 09:19 am | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Nussbaum Ran Director 10% Owner | 0 | $0 | 411,681 (Indirect) | View |
Ownership | 2025-09-10 8:39 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Vida Ventures GP III L.L.C. Vida Ventures III L.P. Vida Ventures III-A L.P. Belldegrun Arie 10% Owner | 0 | $0 | 550,344 (Indirect) | View |
Ownership | 2025-09-10 7:34 pm | N/A 2035-02-10 | LB PHARMACEUTICALS INC | LBRX | Soffer Gad Chief Business Officer | 0 | $0 | 26,893 (Direct) | View |
Ownership | 2025-09-10 7:33 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Deep Track Biotechnology Master Fund Ltd. Deep Track Capital LP KROIN DAVID 10% Owner | 0 | $0 | 686,138 (Direct) | View |
Ownership | 2025-09-10 7:31 pm | N/A 2034-11-17 | LB PHARMACEUTICALS INC | LBRX | Turner Heather D Chief Executive Officer | 0 | $0 | 183,563 (Direct) | View |
Ownership | 2025-09-10 7:22 pm | N/A 2034-03-03 | LB PHARMACEUTICALS INC | LBRX | Garland J. Scott Director | 0 | $0 | 21,514 (Direct) | View |
Ownership | 2025-09-10 7:21 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | PRENSKY ZACHARY Director | 0 | $0 | 139,085 (Direct) | View |
Ownership | 2025-09-10 7:20 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | RUFFOLO ROBERT R Director | 0 | $0 | 15,631 (Direct) | View |
Ownership | 2025-09-10 7:19 pm | N/A N/A | LB PHARMACEUTICALS INC | LBRX | Eramo Anna Chief Medical Officer | 0 | $0 | 36,753 (Direct) | View |